<html>
<head>
    <style>
  * {
    padding: 0;
    margin: 0;
  }
  .fit { /* set relative picture size */
    max-width: 100%;
    max-height: 100%;
  }
  .center {
    display: block;
    margin: auto;
  }
  .dev_margin {
    margin: 20px;
    
  }
  .header {
  	font-weight: bold;
  	font-size:17
  }

  p {
  	margin-top: 5px;
  }

  .normal {
  	font-weight: normal;
  	margin-top: 5px;
  	font-size:17
  }

  .regular {
  	font-weight: normal;
  	font-size:16;
  	margin-top: 5px;
  	text-align: justify;
  }
</style>
</head>
<body>
<div class="dev_margin">
    <p class="header">Product Summary</p>
    <p class="normal"><i>Brand Slogan:</i>The Pure ceftriaxone for sure success</br>
        <i>Dosage Form & Strength:</i>250 mg IV/IM, 500 mg IV/IM, 1 g IV/IM, 2 g IV</br>
        <i>Therapeutic Class:</i>3rd generation cephalosporin's      </br>
        <i>Brand Name Analysis:</i><font color="#f20707"><i>O</i></font>mit the  <font color="#f20707"><i>risk</i></font>=oryx</br>
        <i>Pack Size:</i>1X 1’s, 5X1’s</p>
    <p class="header">Prescribing Information</p>
    <p class="regular"> <strong>Indications:Meningitis, Typhoid Fever, Septicemia,Pnuemonia,Surgical Prophylaxis, Acute Otitis media, Uncomplicated UTIs.    </strong></br>
    <strong>Dosage & Administration: Oryx®</strong></br>
    can be administered either intravenously or intramuscularly. Dosage and mode of administration should be determined by severity of infection, susceptibility of causative organisms and the patient's condition. Under most circumstances, once-daily dose or in the specified indications, a single dose will give satisfactory therapeutic results.</br>
    <strong>Adults and children over 12 years: </strong>The usual dosage is 1-2 g of Oryx® once daily (every 24 hours). In severe cases or in infections caused by moderately sensitive organisms, the dosage may be raised to 4 g once daily.</br>
    <strong>Neonates, infants and children up to 12 years: </strong>The following dosage schedules are recommended for once daily administration. Neonates (up to 14 days): A daily dose of 20-50 mg/kg bodyweight, not to exceed 50 mg/kg, on account of the immaturity of the infant's enzyme systems. It is not necessary to differentiate between premature and term infants. Infants and children (15 days to 12 years): A daily dose of 20-80 mg/kg. For children with bodyweights of 50 kg or more, the usual adult dosage should be used. Intravenous doses of > 50 mg/kg body weight should be given by infusion over at least 30 minutes.</br>
    <strong>Use in pregnancy & lactation:</strong>Levofloxacin is not recommended for use during pregnancy or nursing, as the effects on the unborn child or nursing infant are unknown.</br>
    <strong>Lactation: </strong></br>
    Ceftriaxone is excreted in breast milk at low concentrations.
    </br>Therefore, caution should be exercised when Ceftriaxone is administered to a nursing mother.</br>
    <strong>Preparation:</strong></br>
    <strong>Oryx®: </strong>Injection is supplied as a sterile crystalline powder in glass vials.</br>
    <strong>Oryx®: </strong>250 mg IV Injection : Pack of 1 vial containing 250 mg Ceftriaxone (as sterile Ceftriaxone Sodium USP) accompanied by one ampoule of 5 ml Water for Injection USP for IV injection, a sterile disposable syringe (5 ml) with a baby needle, a butterfly needle, an alcohol prep pad and a strip bandage.</br>
    <strong>Oryx®: </strong>250 mg IM Injection : Pack of 1 vial containing 250 mg Ceftriaxone (as sterile Ceftriaxone Sodium USP) accompanied by one ampoule of 2 ml Lidocaine HCI USP 1% Injection for IM injection, a sterile disposable syringe (5 ml) with a baby needle, an alcohol prep pad and a strip bandage.</br>
    <strong>Oryx®: </strong>500 mg IV Injection : Pack of 1 vial containing 500 mg Ceftriaxone (as sterile Ceftriaxone Sodium USP) accompanied by one ampoule of 5 ml Water for Injection USP for IV injection, a sterile disposable syringe (5 ml) with a baby needle, a butterfly needle, an alcohol prep pad and a strip bandage.</br>
    <strong>Oryx®: </strong>500 mg IM Injection : Pack of 1 vial containing 500 mg Ceftriaxone (as sterile Ceftriaxone Sodium USP) accompanied by one ampoule of 2 ml Lidocaine HCI USP 1% Injection for IM injection, a sterile disposable syringe (5 ml) with a baby needle, an alcohol prep pad and a strip bandage.</br>
    <strong>Oryx®: </strong>1 g IV Injection (Single pack) : Pack of 1 vial containing 1 g Ceftriaxone (as sterile Ceftriaxone Sodium USP) accompanied by one ampoule of 10 ml Water for Injection USP for IV injection, a sterile disposable syringe (10 ml) with an extra needle, a butterfly needle, an alcohol prep pad and a strip bandage.</br>
    <strong>Oryx®: </strong>1 g IV Injection (Five packs): Each box contains 5 blister packs. Each blister pack contains 1 vial containing 1 g Ceftriaxone (as sterile Ceftriaxone Sodium USP) and one ampoule of 10 ml Water for Injection USP for IV injection.</br>
    <strong>Oryx®: </strong>1 g IM Injection : Pack of 1 vial containing 1 g Ceftriaxone (as sterile Ceftriaxone Sodium USP) accompanied by one ampoule of 3.5 ml Lidocaine HCI USP 1% Injection for IM injection, a sterile disposable syringe (5 ml), an alcohol prep pad and a strip bandage.</br>
    <strong>Oryx®: </strong>2 g IV Injection : Pack of 1 vial containing 2 g Ceftriaxone (as sterile Ceftriaxone Sodium USP) and each of two ampoules contains 10 ml Water for Injection USP for IV injection, a sterile disposable syringe (20 ml), a butterfly needle, an alcohol prep pad and a strip bandage.</br>
    
    
</div>

<script src="http://code.jquery.com/jquery-latest.js"></script>
<script type="text/javascript" language="JavaScript">
  function set_body_height() { // set body height = window height
    $('body').height($(window).height());
  }
  $(document).ready(function() {
    $(window).bind('resize', set_body_height);
    set_body_height();
  });
</script>
</body>
</html>





